Your shopping cart is currently empty.
MNEXSPIKE 12+ SYRINGES 2026-2027
MNEXSPIKE (COVID-19 Vaccine, mRNA) injectable suspension, for intramuscular use
2026-2027 Formula
RESERVE NOW
Orders are being accepted and will be released as product becomes available from the manufacturer.
Immediate shipment is not guaranteed and fulfillment is subject to manufacturer availability.
*Reservations orders may be modified anytime.
*Planned change to refrigerated storage at 2C-8C (pending FDA approval).
*Medico-Mart, Inc. is not liable for any manufacturer delays or supply shortages.
Manufacturer: Moderna
Storage Information: NOTE: Planned change to refrigerated storage at 2°C–8°C (pending FDA approval).
Storage
Store frozen between -40°C to -15°C (-40°F to 5°F).
During storage and after thawing, minimize exposure to room light, and avoid exposure to direct
sunlight and ultraviolet light.
After thawing, MNEXSPIKE may be stored refrigerated between 2°C to 8°C (36°F to 46°F) for
up to 90 days or up to the expiration date printed on the carton, whichever comes first.
After thawing, MNEXSPIKE may be stored between 8°C to 25°C (46°F to 77°F) for up to 24
hours.
Do not refreeze once thawed.
Thawed syringes can be handled in room light conditions.
Transportation of Thawed Syringes at 2°C to 8°C (36°F to 46°F)
Thawed prefilled syringes can be transported at 2°C to 8°C (36°F to 46°F) in shipping containers
qualified to maintain 2°C to 8°C (36°F to 46°F). Once thawed and transported at 2°C to 8°C
(36°F to 46°F), prefilled syringes should not be refrozen and should be stored at 2°C to 8°C
(36°F to 46°F) until use.
10 single-dose 0.2ml syringes
Item# 4492-0401-60
NDC# 80777-0401-60
Manufacturer Backorder: Product will be sold at the current price at time of shipping.